Skip to main content
  • 93 Accesses

Zusammenfassung

Die Erforschung der biochemischen, zellulären und subzellulären Mechanismen in der Pathophysiologie des Asthmas hat in den letzten Jahren gezeigt, wie wichtig sterile Entzündungsvorgänge in der Bronchial- schleimhaut zu bewerten sind.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. . Konno S, Asano K, Okamoto K, Adactin M (1994) Inhibition of cytokine production from human perpheral blood leukocytes by anti-allergic agents. Eur J Pharmacol 264: 265 – 268

    Article  PubMed  CAS  Google Scholar 

  2. . Adamus WA, Heur H, Meade CJ, Schilling JC (1990) Inhibitory effects of the new PAF acether

    Google Scholar 

  3. antagonist WEB 2086 on pharmacological changes induced by PAF inhalation in human beings. Clin Pharmacol Ther 47: 456–462

    Google Scholar 

  4. . Robaut C, Mundot S, Florh A, Tahroui L (1988) Pharmacological profile of novel potent and specific PAF rezeptor antagonists. Prostaglandins 35: 838 – 844

    Article  Google Scholar 

  5. . Chung F (1988) New approaches to asthma: antagonists of PAF. New drugs for asthma. IBC, London

    Google Scholar 

  6. . Chung FK (1995) Leukotriene receptor antagonists and biosynthesis inhibitors: potential breakthrough in asthma therapy. Eur Respir J 8: 1203 – 1213

    Article  PubMed  CAS  Google Scholar 

  7. . von Sprecher A, Beck A, Gerspacher M, Bray MA (1992) Peptidoleukotriene Antagonists, state of the art. Chimia 46: 304 – 331

    Google Scholar 

  8. . Lipworth BJ (1999) Leukotrien-receptor antagonists. Lancet 353: 57 – 62

    Article  PubMed  CAS  Google Scholar 

  9. . Papi A, Caramori G, Fabbri LM (1998) Current asthma therapies and issues in asthma management. Eur Respir Rev 8: 341 – 347

    Google Scholar 

  10. . Lu S, Reiss TF (1998) The dose selection of montelukast sodium (MK-0476). Eur Respir Rev 8: 361 – 365

    Google Scholar 

  11. . Barnes NC (1998) The role of leukotriene receptor antagonists in the management oft asthma. Eur Respir Rev 8: 356 – 357

    Google Scholar 

  12. . Drazen JM, Israel E, Wenzel SE (1998) Should antileukotriene therapie be used instead of inhaled corticosteroids in asthma? Yes or no. Editorial Am J Respir Crit Care Med 158: 1697 – 1701

    CAS  Google Scholar 

  13. Tallard RE, Gearing AJH (1994) The cytokine facts book (Acad Press)

    Google Scholar 

  14. . Aggarwal BB, Guttermann JU (1992) Human cytokines: handbook for basic and clinical research. Blackwell Scientific, Oxford

    Google Scholar 

  15. . Rao A (1994) NF-ATp: A transcriptional factor required for the co-ordinate induction of several cytokine genes. Immunol Today 15: 274 – 281

    Article  PubMed  CAS  Google Scholar 

  16. . Akdis CA, Blesken T, Akdis M, Alkan SS, Heusser CH, Blaser K (1997) Glucocorticoids inhibit antigen-specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro. Eur J Immunol 2351 – 2357

    Google Scholar 

  17. . Wong, RL, Winslaw CM, Cooper KD (1993) The mechanisms of action of cyclosporin A in the treatment of psoriasis. Immunol Today 14: 69 – 74

    Article  PubMed  CAS  Google Scholar 

  18. . Erlanger B (1992) Do we know the site of action of cyclosporin? Immunol Today 13: 487 – 489

    Article  PubMed  CAS  Google Scholar 

  19. . Schreiber SC, Cabtree GR (1992) The mecha-nism of action of cyclosporin and FK506. Immunol Today 13: 136 – 142

    Article  PubMed  CAS  Google Scholar 

  20. . Tokuyama H, Tokuyama Y, Nkanishi K (1995) Retinoids inhibit IL-4 dependent IgE and IgG production by LPS-stimulation murine splenic B cells. Cell Immunol 162: 153 – 158

    Article  PubMed  CAS  Google Scholar 

  21. . Redlich CA, Delisser HM, Elias JA (1995) Retinoic acid inhibition of transforming growth factor bbb-induced collagen production by human lung fibroblasts. Am J Resp Cell Mol Biol 12: 287 – 295

    CAS  Google Scholar 

  22. . Fegan C, Bailgy-Wood R, Coleman S, Philipps SA, Neale L, Hoy T, Whittaker JA (1995) All-trans retonoic acid enhances human LAK activity. Eur J Haematol 54: 95 – 100

    Article  PubMed  CAS  Google Scholar 

  23. . Chanarin N, Johnston SL (1994) Leukotrienes as a target in asthma therapy. Drugs 47 (1): 12 – 24

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag/Wien

About this chapter

Cite this chapter

Schöni, M.H., Blaser, K. (2000). Hemmer von Mediatoren und Zytokinen. In: Kummer, F., Konietzko, N., Medici, T.C. (eds) Pharmakotherapie bronchopulmonaler Erkrankungen. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6761-8_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6761-8_9

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7404-3

  • Online ISBN: 978-3-7091-6761-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics